Mesenchymal Stem Cell and MicroRNA Therapy of Musculoskeletal Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 홍일화 | - |
dc.contributor.author | Chung, Myung-Jin | - |
dc.contributor.author | Son, JY (Son, Ji-Yoon) | - |
dc.contributor.author | Park, S (Park, SunYoung) | - |
dc.contributor.author | Park, SS (Park, Soon-Seok) | - |
dc.contributor.author | Hur, K (Hur, Keun) | - |
dc.contributor.author | Lee, SH (Lee, Sang-Han) | - |
dc.contributor.author | Lee, EJ (Lee, Eun-Joo) | - |
dc.contributor.author | Park, JK (Park, Jin-Kyu) | - |
dc.contributor.author | Kim, TH (Kim, Tae-Hwan) | - |
dc.contributor.author | Jeong, KS (Jeong, Kyu-Shik)... | - |
dc.date.accessioned | 2022-12-26T10:16:28Z | - |
dc.date.available | 2022-12-26T10:16:28Z | - |
dc.date.issued | 2021-05 | - |
dc.identifier.issn | 2005-3606 | - |
dc.identifier.issn | 2005-5447 | - |
dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/3733 | - |
dc.description.abstract | The therapeutic effects of mesenchymal stem cells (MSCs) in musculoskeletal diseases (MSDs) have been verified in many human and animal studies. Although some tissues contain MSCs, the number of cells harvested from those tissues and rate of proliferation in vitro are not enough for continuous transplantation. In order to produce and maintain stable MSCs, many attempts are made to induce differentiation from pluripotent stem cells (iPSCs) into MSCs. In particular, it is also known that the paracrine action of stem cell-secreted factors could promote the regeneration and differentiation of target cells in damaged tissue. MicroRNAs (miRNAs), one of the secreted factors, are small non-coding RNAs that regulate the translation of a gene. It is known that miRNAs help communication between stem cells and their surrounding niches through exosomes to regulate the proliferation and differentiation of stem cells. While studies have so far been underway targeting therapeutic miRNAs of MSDs, studies on specific miRNAs secreted from MSCs are still minimal. Hence, our ultimate goal is to obtain sufficient amounts of exosomes from iPSC-MSCs and develop them into therapeutic agents, furthermore to select specific miRNAs and provide safe cell-free clinical setting as a cell-free status with purpose of delivering them to target cells. This review article focuses on stem cell therapy on MSDs, specific microRNAs regulating MSDs and updates on novel approaches. | - |
dc.format.extent | 18 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN SOC STEM CELL RESEARCH | - |
dc.title | Mesenchymal Stem Cell and MicroRNA Therapy of Musculoskeletal Diseases | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF STEM CELLS, v.14, no.2, pp 150 - 167 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF STEM CELLS | - |
dc.citation.volume | 14 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 150 | - |
dc.citation.endPage | 167 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.